Found: 10
Select item for more details and to access through your institution.
(DXT59) The CLARITY Study: Efficacy Outcomes Among Patients Who Received Disease-Modifying Drugs Prior to Treatment with Cladribine Tablets.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 37
- By:
- Publication type:
- Article
Desirability and acceptability of a treatment-sequencing model in relapsing-remitting multiple sclerosis: A health technology assessment perspective.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Summarizing Patient Preferences for the Competitive Landscape of Multiple Sclerosis Treatment Options.
- Published in:
- Medical Decision Making, 2020, v. 40, n. 2, p. 198, doi. 10.1177/0272989X19897944
- By:
- Publication type:
- Article
Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands.
- Published in:
- Applied Health Economics & Health Policy, 2019, v. 17, n. 6, p. 857, doi. 10.1007/s40258-019-00500-8
- By:
- Publication type:
- Article
Consequences of Biomarker Analysis on the Cost-Effectiveness of Cetuximab in Combination with FOLFIRI as a First-Line Treatment of Metastatic Colorectal Cancer: Personalised Medicine at Work.
- Published in:
- Applied Health Economics & Health Policy, 2018, v. 16, n. 4, p. 515, doi. 10.1007/s40258-018-0395-5
- By:
- Publication type:
- Article
Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing–Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing–Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 2, p. 892, doi. 10.1007/s12325-021-01975-5
- By:
- Publication type:
- Article
Efficiency Model of Cladribine Tablets Versus Infusion-Based Disease-Modifying Drugs for Patients with Relapsing-Remitting Multiple Sclerosis.
- Published in:
- Advances in Therapy, 2020, v. 37, n. 9, p. 3791, doi. 10.1007/s12325-020-01426-7
- By:
- Publication type:
- Article
Assessing the Long-Term Effectiveness of Cladribine vs. Placebo in the Relapsing-Remitting Multiple Sclerosis CLARITY Randomized Controlled Trial and CLARITY Extension Using Treatment Switching Adjustment Methods.
- Published in:
- 2020
- By:
- Publication type:
- journal article